Stockreport

Presbyopia Treatment Market Set to Reach New Heights with New Therapies and Advancements by 2034 | DelveInsight [Yahoo! Finance]

Viatris Inc.  (VTRS) 
PDF PF (VT-1011) by Visus Therapeutics, among others will significantly impact the presbyopia market during the forecast period (2024–2034). LAS VEGAS Nov. 14, 2024 /PRNew [Read more]